309.12

-0.46%↓

RTX

178.68

+0.84%↑

GEV.US

584.67

+1.83%↑

HON

201.42

+0.96%↑

UNP

220.77

+0.88%↑

309.12

-0.46%↓

RTX

178.68

+0.84%↑

GEV.US

584.67

+1.83%↑

HON

201.42

+0.96%↑

UNP

220.77

+0.88%↑

309.12

-0.46%↓

RTX

178.68

+0.84%↑

GEV.US

584.67

+1.83%↑

HON

201.42

+0.96%↑

UNP

220.77

+0.88%↑

309.12

-0.46%↓

RTX

178.68

+0.84%↑

GEV.US

584.67

+1.83%↑

HON

201.42

+0.96%↑

UNP

220.77

+0.88%↑

309.12

-0.46%↓

RTX

178.68

+0.84%↑

GEV.US

584.67

+1.83%↑

HON

201.42

+0.96%↑

UNP

220.77

+0.88%↑

Strona główna・Stock List・India Globalization Capital Inc

India Globalization Capital Inc

Closed

0.39

Buy Sell

Overview

Share price change

24h

Current

Min

0.38

Max

0.39

Key metrics
By Trading Economics
Income	-402K -1.6M
Sales	-2K 328K
Profit margin	-487.5
Employees	70
EBITDA	-506K -1.8M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+1025% upside

Dividends
By Dow Jones
Next Earnings	10 lis 2025

Market Stats
By TradingEconomics
Market Cap	9.1M 38M
Previous open	0.39
Previous close	0.39

India Globalization Capital Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

31 paź 2025, 17:40 UTC

Acquisitions, Mergers, Takeovers

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

1 lis 2025, 12:56 UTC

Earnings

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

1 lis 2025, 12:56 UTC

Earnings

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 lis 2025, 12:20 UTC

Earnings

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 lis 2025, 12:19 UTC

Earnings

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 lis 2025, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1 lis 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 lis 2025, 00:10 UTC

Earnings

Trouble on The Strip -- Barrons.com

31 paź 2025, 23:09 UTC

Earnings

Review & Preview: October Surprise -- Barrons.com

31 paź 2025, 22:44 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 paź 2025, 21:25 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31 paź 2025, 21:20 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31 paź 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31 paź 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 paź 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31 paź 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31 paź 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

31 paź 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 paź 2025, 20:50 UTC

Market Talk

Earnings

Auto & Transport Roundup: Market Talk

31 paź 2025, 20:46 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31 paź 2025, 20:22 UTC

Earnings

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31 paź 2025, 20:02 UTC

Earnings

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31 paź 2025, 19:55 UTC

Market Talk

Crude Futures Fall for Third Straight Month -- Market Talk

31 paź 2025, 19:54 UTC

Acquisitions, Mergers, Takeovers

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31 paź 2025, 19:54 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31 paź 2025, 19:26 UTC

Market Talk

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31 paź 2025, 18:30 UTC

Earnings

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31 paź 2025, 18:23 UTC

Market Talk

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31 paź 2025, 18:09 UTC

Earnings

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 paź 2025, 18:08 UTC

Earnings

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Peer Comparison

Price change

India Globalization Capital Inc Forecast

Price Target

By TipRanks

1025% upside

12 Months Forecast

Average 4.5 USD 1025%

High 4.5 USD

Low 4.5 USD

Based on 1 Wall Street analysts offering 12 month price targets forIndia Globalization Capital Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to India Globalization Capital Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.